Novel pharmacotherapies and patents for alcohol abuse and alcoholism 1998-2001

Bibliography

• MORSE RM, FLAVIN DK: The definition alcoholism. J. Am. Med. Assoc. (1992) 268:1012–1014.
   PubMed Web of Science ®Google Scholar
• AMERICAN PSYCHIATRIC: Diagnostic and Statistical Manual of Mental Disorders. 4th Ed. (1994) Washington, DC, APA.
   Google Scholar
• HOLBROOK AM, CROWTHER R, LOTTER A, CHENG C, KINK D: Diagnosis and management of acute alcohol withdrawal. Can. Med. Assoc. j (1999) 160:675–680.
   PubMed Web of Science ®Google Scholar
• •Excellent review on diagnosis and therapy of alcohol withdrawal syndrome.
   Google Scholar
• NATIONAL INSTITUTE OF ALCOHOL ABUSE AND ALCOHOLISM: The Physician's Guide to Helping Patients with Alcohol Problems. (1995) National Institute of Health. publication no. 95–3769. Bethesda, MD, National Institute of Alcohol Abuse and Alcoholism.
   Google Scholar
• ISAACSON JH, SCHORLING JB: Screening for alcohol problems in primary care. Med. OM. North Am. (1999) 83:1547–1563.
   PubMedGoogle Scholar
• REGIER DA, FARMER ME, RAE DS etal.: Comorbidity of mental disorders with alcohol and other drug abuse. rResults from the epidemiologic catchment area (ECA) study. J Am. Med. Assoc. (1990) 264:2511–2518.
   Google Scholar
• JERNIGAN DH, MONTEIRO M, ROOM R, SAXENA S: Towards a global alcohol policy: alcohol, public health and the role of WHO. Bull. WHO (2000) 78:491–499.
   PubMed Web of Science ®Google Scholar
• LIEBER CS: Medical disorders of. N Engl. j Med. (1995) 333:1058–1065.
   PubMed Web of Science ®Google Scholar
• •Seminal paper in the alcohol field.
   Google Scholar
• MAN WELL LB, FLEMING M: Harmful alcohol consumption. In: Handbook of Alcoholism. Zernig G, Saria A, kurz M, O'Malley SS (Eds.), CRC Press, Boca Raton, USA (2000):325–329.
   Google Scholar
• GARBUTT JG, WEST SL, CAREY TS, LOHOR KN, CREWS FT: Pharmacological treatment of alcohol dependence. A review of the evidence. Am. Med Assoc. (1999) 281:1318–1325.
   PubMed Web of Science ®Google Scholar
• ••Critical evaluation of all presently used for alcoholism; this paper includes an original and effective rating of pharmacotherapies.
   Google Scholar
• KRANZLER HR: Pharmacotherapy of alcoholism: gaps in knowledge and opportunities for research. Alcohol Alcohol. (2000) 35:537–547.
   PubMed Web of Science ®Google Scholar
• ••Excellent and recent review onpharmacotherapies for alcoholism.
   Google Scholar
• SWIFT RM: Drug therapy for alcohol dependence. N. Engl. J. Med. (1999) 340:1482–1490.
   PubMed Web of Science ®Google Scholar
• ••Excellent and recent review onpharmacotherapies for alcoholism.
   Google Scholar
• SCHUCKIT MA: Drug and Alcohol Abuse: A Clinical Guide to Diagnosis and Treatment. Woods SM (Ed.), Plenum Publishing Co., New York, USA, 4th edition (1995).
   Google Scholar
• •A rather recent book constituting a comprehensive essay on alcoholism.
   Google Scholar
• GOLDSTEIN DB, CHIN JH: Interaction ethanol with biological membranes. Fed. Proc. (1981) 40:2073–2076.
   PubMedGoogle Scholar
• •Landmark paper on the disordering action of alcohol on cell membranes.
   Google Scholar
• GRANT KA: Emerging neurochemical concepts in the actions of ethanol at ligand-gated ion channels. Behav. Pharmacol (1994) 5:383–404.
   PubMed Web of Science ®Google Scholar
• KOOB GF, RASSNICK S, HEINRICHS S, WEISS F: Alcohol, the reward system and dependence. In: Toward a Molecular Basis of Alcohol Use and Abuse. Jansson B, Jornvall H, Rydberg U, Terenius L, Vallee BL (Eds.) Birkäuser, Basel, Switzerland (1994):103–114.
   Google Scholar
• GRANT KA, COLOMBO G:
   Google Scholar
• •First behavioral evidence of the antagonistic effect of alcohol at the glutamate NMDA receptor.
   Google Scholar
• GRANT KA, COLOMBO G: Substitution of the 5-HT1 agonist trifluoromethylphenylpiperazine (TFMPP) for the discriminative stimulus effect of ethanol: effects of training dose. Psychopharmacology (1993) 113:26–30.
   PubMedGoogle Scholar
• WILLIAMS-HEMBY L, GRANT KA, GJ, PORRINO LJ: Cerebral metabolic mapping of the discriminative stimulus effects of ethanol. Alcohol. Clin Exp. Res. (1994) 18:520.
   Google Scholar
• POHORECKY LA: Biphasic action of ethanol. Biobehav. Rev (1977) 1:231–240.
   Web of Science ®Google Scholar
• MACDONALD RL, OLSEN RW: GABAA receptor channels. Ann. Rev. Neurosci. (1994) 17:569–602.
   PubMed Web of Science ®Google Scholar
• PRITCHETT DB, SONTHEIMER H, SHIVERS B et al: Importance of a novel GABAA receptor subunit for benzodiazepine pharmacology. Nature (1989) 338:582–585.
   PubMed Web of Science ®Google Scholar
• NESTOROS JN: Ethanol specifically potentiates GABA-mediated neurotransmission in feline cerebral cortex. Science (1980) 209:708–710.
   PubMed Web of Science ®Google Scholar
• SUZDAK PD, GLOWA JR, CRAWLEY JN, SCHWARTZ RD, SKOLNICK P, PAUL SM: A selective imidazobenzodiazepine antagonist of ethanol in the rat. Science (1986) 234:1243–1247.
   PubMed Web of Science ®Google Scholar
• •The paper that opened an avenue of research with benzodiazepine inverse agonists as possible alcohol "antagonists".
   Google Scholar
• CELENTANO JJ, GIBBS TT, FARB DH: potentiates GABA- and glycine-induced chloride currents in chick spinal cord neurons. Brain Res. (1988) 455:377–380.
   PubMedGoogle Scholar
• METHA AK, TICKU MK: Ethanol potentiation of GABAergic transmission in cultured spinal cord neurons involves GABA-gated chloride channels. Exp. Ther. (1988) 246:558–564.
   PubMedGoogle Scholar
• AGUAYO LG: Ethanol potentiates the GABAA-activated Cl- current in mouse hippocampal and cortical neurons. Eur. Pharmacol (1990) 187:127–130.
   PubMedGoogle Scholar
• REYNOLDS JN, PRASAD A: Ethanol enhances GABAA receptor-activated chloride currents in chick cerebral cortical neurons. Brain Res. (1991) 564:138–142.
   PubMedGoogle Scholar
• WHITE G, LOVINGER DM, WEIGHT FF: Ethanol inhibits NMDA-activated current but does not alter GABA-activated current in an isolated adult mammalian neuron. Brain Res. (1990) 507:332–336.
   PubMed Web of Science ®Google Scholar
• MIHIC SJ, WU PH, KALANT H: Potentiation of y-aminobutyirc acid-mediated chloride flux by pentobarbital and diazepam but not ethanol. ..J. Neurochem. (1992) 58:745–751.
   PubMedGoogle Scholar
• GIVENS BS, BREESE GR: Site-specific enhancement of y-aminobutyric acid-mediated inhibition of neural activity by in the rat medial septal area. Pharmacol Exp. Ther. (1990) 254:528–538.
   PubMedGoogle Scholar
• WAFFORD KA, BURNETT DM, LEIDENHEIMER NJ etal.: Ethanol sensitivity of the GABAA receptor expressed in Xenopus oocytes requires 8 amino acids contained in the g2L subunit. Neuron (1991) 7:27–33.
   Google Scholar
• WAFFORD KA, WHITING PJ: Ethanol potentiation of GABA(A) receptors requires phosphorylation of the alternatively spliced variant of the g2 subunit. FEBS Lett. (1992) 313:113–117.
   PubMedGoogle Scholar
• BARBACCIA ML, AFFRICANO D, TRABUCCHI M etal.: Ethanol markedly increases 'GABAergic neurosteroids in alcohol-preferring rats. Eur. j Pharmacol (1999) 384:R1–R2.
   Google Scholar
• KOSTOWSKI W, BIENKOWSKI P: Discriminative stimulus effects of ethanol: neuropharmacological characterization. Alcohol (1999) 17:63–80.
   PubMed Web of Science ®Google Scholar
• GROBIN AC, MATTHEWS DB, DEVAUD LL, MORROW L: The role of GABAA receptors in the acute and chronic effects of ethanol. Psychopharmacology (1998) 139:2–19.
   PubMed Web of Science ®Google Scholar
• •Recent, up-to-date review on the interaction between alcohol and the GABAA receptor complex.
   Google Scholar
• REES DC, BALSTER RL: Attenuation of the discriminative stimulus properties of ethanol and oxazepam, but not of pentobarbital, by Ro 15-4513 in mice. Pharmacol Exp. Ther. (1988) 244:592–598.
   PubMedGoogle Scholar
• LISTER RG, DURCAN MJ: Antagonism of the intoxicating effects of ethanol by the potent benzodiazepine receptor ligand Ro 19-4603. Brain Res. (1989) 482:141–144.
   PubMedGoogle Scholar
• BECKER HC, HALE RL: RO 15-4513 antagonizes the anxiolytic effects of ethanol in a nonshock conflict task at doses devoid of anxiogenic activity. Pharmacol Biochem. Behav. (1991) 39:803–807.
   PubMedGoogle Scholar
• DAR MS: Antagonism by intracerebellar Ro 15-4513 of acute ethanol-induced motor incoordination in mice. Pharmacol Biochem. Behav. (1995) 52:217–223.
   PubMedGoogle Scholar
• GATTO GJ, GRANT KA: Attenuation of the discriminative stimulus effects of ethanol by the benzodiazepine partial inverse agonist Ro 15-4513. Behav. Pharmacol (1997) 8:139–46.
   PubMedGoogle Scholar
• LINNOILA M: Benzodiazepines and alcohol. I Psychiat. Res. (1990) 24\(Suppl. 2):121–127.
   Google Scholar
• BECKER HC, ANTON RF: The receptor inverse agonist RO 15-4513 exacerbates, but does not precipitate, ethanol withdrawal in mice. Pharmacol. Biochem. Behav. (1989) 32:163–167.
   PubMedGoogle Scholar
• DAOUST M, SALIGAUT C, LHUINTRE JP, MOORE N, FLIPO JL, BOISMARE F: GABA transmission, but not benzodiazepine receptor stimulation, modulates ethanol intake by rats. Alcohol (1987) 4:469–472.
   PubMedGoogle Scholar
• COLOMBO G, AGABIO R, CARAT MAM, et al: Ability of baclofen in reducing alcohol intake and withdrawal severity: I - Preclinical evidence. Alcohol. OM. Exp. Res. (2000) 24:58–66.
   PubMed Web of Science ®Google Scholar
• COTT J, CARLSSON A, ENGEL J, LINDQVIST M: Suppression of ethanol-induced locomotor stimulation by GABA-like drugs. Naurryn-Schmiedebergs Arch. Pharmacol. (1976) 295:203–209.
   PubMed Web of Science ®Google Scholar
• CHESTER JA, CUNNINGHAM CL: Baclofen alters ethanol-stimulated activity but not conditioned place preference or taste aversion in mice. Pharmacol Biochem. Behav. (1999) 63:325–331.
   PubMed Web of Science ®Google Scholar
• FILE SE, ZHARKOVSKY A, GULATI K: Effects of baclofen and nitrendipine on ethanol withdrawal responses in the rat. Neuropharmacology (1991) 30:183–190.
   PubMed Web of Science ®Google Scholar
• TICKU MK: Alcohol and GABA-benzodiazepine receptor function. Ann. Med. (1990) 22:241–246.
   PubMedGoogle Scholar
• FRYE GD, FINCHER A: Sensitivity of postsynaptic GABAB receptors on hippocampal CA1 and CA3 pyramidal neurons to ethanol. Brain Res. (1996) 735:239–248.
   PubMedGoogle Scholar
• MOLLEMANN A, LITTLE HJ: Increases in non-methyl-D-aspartate glutamatergic transmission, but no change in gamma-aminobutyric acideransmission, in CA1 neurons during withdrawal in vivo chronic ethanol treatment. j Pharmacol Exp. Ther. (1995) 274:1035–1041.
   PubMedGoogle Scholar
• MISGELD U, BIJAK M, JAROLIMEK W: A physiological role for GABAB receptors and the effects of baclofen in the mammalian central nervous system. Prog. Neurobiol (1995) 46:423–462.
   PubMed Web of Science ®Google Scholar
• YOSHIDA M, YOKOO H, TANAKA T, EMOTO H, TANAKA M: Opposite changes in the mesolimbic metabolism in the nerve terminal and cell body sites induced by locally infused in the rat. Brain Res. (1994) 636:111–114.
   PubMed Web of Science ®Google Scholar
• HOLBROOK AM, CROWTHER R, A, CHENG C, KINK D: Meta-analysis of benzodiazepine use in the treatment of acute alcohol withdrawal. Can. Med. Assoc. j (1999) 160:649–655.
   PubMed Web of Science ®Google Scholar
• MAYO-SMITH MF: Pharmacological management of alcohol withdrawal. I Am. Med. Assoc. (1997) 278:144–151.
   PubMed Web of Science ®Google Scholar
• ••Excellent and authoritative review onpharmacotherapy for alcohol withdrawal syndrome.
   Google Scholar
• ADDOLORATO G, CAPUTO F, CAPRISTO E, COLOMBO G, GESSA GL, GASBARRINI G: Ability of baclofen in reducing alcohol craving and intake: II - Preliminary clinical evidence. Alcohol. OM. Exp. Res. (2000) 24:67–71.
   PubMed Web of Science ®Google Scholar
• •This paper contains promising data on the potential efficacy of baclofen in inducing and maintaining abstinence in alcoholics.
   Google Scholar
• COLOMBO G, GESSA GL: Gamma-hydroxybutyric acid in alcohol preference, dependence and withdrawal. Addict. Biol. (2000) 5:389–403.
   PubMedGoogle Scholar
• AGABIO R, GESSA GL: Therapeutic uses of GHB. In: y-Hydroxybutyrate: Pharmacological and Functional Aspects. CAsh DC, Tunniclid G. (Eds.), Gordon and Breach Scientific Publishers, Newark, USA (2001) in press.
   Google Scholar
• GALLIMBERTI L, FERRI M, FERRARA SD, FADDA F, GESSA GL: Gamma-hydroxybutyric acid in the treatment of alcohol dependence: a double-blind study. Alcohol. OM. Exp. Res. (1992) 16:673–676.
   PubMed Web of Science ®Google Scholar
• ADDOLORATO G, CASTELLI E, STEFANINI GF etal.: An open multicentric study evaluating 4-hydroxybutyric acid sodium salt in the medium-term treatment of 179 alcohol dependent subjects. A/colto/A/coltd. (1996) 31:341–345.
   Google Scholar
• MORI H, MISHINA M: Structure and function of the NMDA receptor channel. Neuropharmacology (1995) 34:1219–1237.
   Google Scholar
• HOFFMAN PL, RABE CS, MOSES F, TABAKOFF B: N-methyl-D-aspartate receptors and ethanol: inhibition of calcium flux and cyclic GMP production. Neurocliem. (1989) 52:1937–1940.
   Google Scholar
• LOVINGER DM, WHITE G, WEIGHT FF: Ethanol inhibits NMDA-activated ion current in hippocampal neurons. Science (1989) 243:1721–1724.
   PubMed Web of Science ®Google Scholar
• ••First evidence on alcohol functioning as anantagonist at the glutamate NMDA receptor.
   Google Scholar
• DILDY JE, LESLIE SW: Ethanol inhibits NMDA-induced increases in free intracellular Ca2+ in dissociated brain cells. Brain Res. (1989) 499:383–387.
   PubMed Web of Science ®Google Scholar
• WHITE G, LOVINGER DM, WEIGHT FF: Ethanol inhibits NMDA-activated current but does not alter GABA-activated current in an isolated adult mammalian neuron. Brain Res. (1990) 507:332–326.
   PubMed Web of Science ®Google Scholar
• LOVINGER DM, WHITE G, WEIGHT FF: NMDA receptor-mediated synaptic excitation selectively inhibited by ethanol in hippocampal slice from adult rat.. (1990) 10:1372–1379.
   Google Scholar
• DILDY-MAYFIELD JE, LESLIE SW: Mechanism of inhibition of N-methyl-D-aspartate-stimulated increases in free intracellular Ca2+ concentration by ethanol.. (1991) 56:1536–1543.
   Google Scholar
• SNELL LD, TABAKOFF B, HOFFMAN PL: Radioligand binding to the N-methyl-aspartate receptor/ionophore complex: Alterations by ethanol in vitro and by chronic in vivo ethanol ingestion. Brain Res. (1993) 602:91–98.
   PubMed Web of Science ®Google Scholar
• MORRISETT RA, MARTIN D, OETTING TA, LEWIS DV, WILSON WA, SWARTZWELDER HS: Ethanol and magnesium ions inhibit N-methyl-D-aspartate-mediated synaptic potentials in an interactive manner. Neuropharmacology (1991) 30:1173–1178.
   PubMedGoogle Scholar
• MARTIN D, MORRISETT RA, BAIN X-P, WILSON WA, SWARTZ WELDER HS: Ethanol inhibition of NMDA mediated depolarizations is increased in the presence of Mg2±. Brain Res. (1991) 546:227–234.
   PubMedGoogle Scholar
• RABE CS, TABAKOFF B: Glycine site-directed agonists reverse the actions of ethanol at the N-methyl-D-aspartate receptor. Ma Pharmacol (1990) 38:753–757.
   PubMed Web of Science ®Google Scholar
• GRANT KA, KNISELY JS, TABAKOFF B,BARRETT JE, BALSTER RL: Ethanol-like discriminative stimulus effects of non-competitive N-methyl-D-aspartate antagonists. Behav. Pharmacol (1991) 2:87–92.
   PubMedGoogle Scholar
• SANGER DJ: Substitution by NMDA antagonists and other drugs in rats trained to discriminate ethanol. Behav. Pharmacol (1993) 4:523–528.
   PubMedGoogle Scholar
• SCHECHTER MD, MEEHAN SM, GORDON TL, MCBURNEY DM: The NMDA receptor antagonist MK-801 produces ethanol-like discrimination in the rat. Alcohol (1993) 10:197–201.
   PubMedGoogle Scholar
• SHELTON KL, BALSTER R: Ethanol discrimination in rats: Substitution with GABA agonists and NMDA antagonists. Behav. Pharmacol (1994) 5:441–450.
   PubMedGoogle Scholar
• AZAROV AV, PURDY RH, GRANT KA: The discriminative stimulus effects of ethanol in cynomolgus monkeys (Maraca Fascicularis). Alcohol. Chit. Esp. Res. (1995) 19 Suppl.:63A.
   Google Scholar
• KRYSTAL JH, PETRAKIS IL, WEBB E et al.: Dose-related ethanol-like effects of the NMDA antagonist, ketamine, in recently detoxified alcoholics. Arch. Gen. Psychiatry (1998) 55:354–360.
   PubMed Web of Science ®Google Scholar
• •Evidence of the alcohol-like subjective feelings of ketamine in humans.
   Google Scholar
• SCHUTZ CG, SOIKA M: challenge in alcohol-dependent patients and controls. Arch. Gen. Psychiatry (2000) 57:291–292.
   PubMedGoogle Scholar
• LILJEQUIST S: NMDA receptor antagonists inhibit ethanol-produced locomotor stimulation in NMRI mice. Alcohol (1991) 8:309–312.
   PubMedGoogle Scholar
• HOLTER SM, DANYSZ W, SPANAGEL R: Evidence for alcohol anti-craving properties of memantine. Eur. j Pharmacol (1996) 314:R1–R2.
   PubMed Web of Science ®Google Scholar
• HOLTER SM, DANYSZ W, SPANAGEL R: Novel uncompetitive N-methyl-D-aspartate (NMDA)-receptor antagonist MRZ 2/579 suppresses ethanol intake in long-term ethanol-experienced rats and generalizes to ethanol cue in drug discrimination procedure. j Pharmacol Exp. Ther. (2000) 292:545–552.
   PubMed Web of Science ®Google Scholar
• BIENKOSWKY P, KOROS E, W; DANYSZ W: Effects of N-methyl-D-aspartate receptor antagonists on reinforced and nonreinforced responding for ethanol in rats. Alcohol (1999) 18:131–137.
   PubMedGoogle Scholar
• GRANT KA, VALVERIUS P, HUDSPITH, TABAKOFF B: Ethanol withdrawal seizures and the NMDA receptor complex. Eur. Pharmacol (1990) 176:289–296.
   PubMed Web of Science ®Google Scholar
• •First evidence of the maladaptation of the NMDA receptor system in the alcohol withdrawal syndrome.
   Google Scholar
• VALVERIUS P, CRABBE JC, HOFFMAN PL, TABAKOFF B: NMDA receptors in mice bred to be prone or resistant to ethanol withdrawal seizures. Eur. j Pharmacol (1990) 184:185–190.
   PubMedGoogle Scholar
• GULYA K, GRANT KA, VALVERIUS P, HOFFMAN PL, TABAKOFF B: Brain regional specificity and time course of in the NMDA receptor-ionophore complex during ethanol withdrawal. Brain Res. (1991) 547:129–134.
   PubMed Web of Science ®Google Scholar
• GRANT KA, SNELL LD, ROGAWSKI MA, THURKAUF A, TABAKOFF B: Comparison of the effects of the uncompetitive N-methyl-D-aspartate antagonist (-4-5-aminocarbony1-10,11-dihydro-5H-dibenzo la, cll cyclo hepten-5, 10-imine (AD CI) with its structural analogs dizolcipine (MK-801) and carbamazepine on ethanol withdrawal seizures. Esp. Ther. (1992) 260:1017–1022.
   PubMedGoogle Scholar
• IORIO KR, REINLIB L, TABAKOFF B,HOFFMAN PL: Chronic exposure of cerebellar granule cells to ethanol results in increased N-methyl-D-aspartate receptor function. I Pharmacol. Exp. Ther. (1992) 41:1142–1148.
   Google Scholar
• SANNA E, SERRA M, COSSU A et al: Chronic ethanol intoxication induces differential effects on GABAA and NMDA receptor function in the rat brain. Alcohol. Chit. Exp. Res. (1993) 17:115–123.
   PubMed Web of Science ®Google Scholar
• TREVISAN L, FITZGERALD LW, BROSE N et al.: Chronic ingestion of ethanol up-regulates NMDAR1 receptor subunit immunoreactivity in rat hippocampus. j Neurochem. (1994) 62:1635–1638.
   PubMedGoogle Scholar
• LILJEQUIST S: The competitive NMDA receptor antagonist, CGP 39551, inhibits ethanol withdrawal seizures. Eur. Pharmacol (1991) 192:197–198.
   PubMedGoogle Scholar
• ERDEN BF, OZDEMIRCI S, YILDIRAN G, UTKAN T, GACAR N, ULAK G: Dextromethorphan attenuates ethanol withdrawal syndrome in rats. Pharmacol Biochem. Behav. (1999) 62:537–541.
   PubMed Web of Science ®Google Scholar
• KHANNA JM, WU PH, WEINER J, KALANT H: NMDA antagonist inhibits rapid tolerance to ethanol. Brain Res. Bull. (1991) 26:643–645.
   PubMedGoogle Scholar
• WU PH, MIHIC SJ, LIU J-F, LE AD, KALANT H: Blockade of chronic tolerance to ethanol by the NMDA antagonist, (+)-MK-801. Eur. Pharmacol (1993) 231:157–164.
   PubMedGoogle Scholar
• KIYATKIN EA: Functional significance ofmesolimbic dopamine. Neurosci. Biobehav. Rev (1995) 19:573–598.
   PubMedGoogle Scholar
• MEREU G, FADDA F, GESSA GL: Ethanol stimulates the firing rate of nigral dopaminergic neurons in unanesthetized rats. Brain Res. (1984) 292:63–69.
   PubMed Web of Science ®Google Scholar
• •First evidence of the alcohol activating on dopamine neurones.
   Google Scholar
• GESSA GL, MUNTONI F, COLLU M, VARGIU L, MEREU G: Low doses of ethanol activate dopaminergic neurons in the ventral tegmental area. Brain Res. (1985) 348:201–203.
   PubMed Web of Science ®Google Scholar
• MEREU G, GESSA GL: Low doses of ethanol inhibit the firing of neurons in the substantia nigra, pars reticulate: a GABAergic effect? Blain Res. (1985) 360:325–330.
   Google Scholar
• CARLSSON A, LINDQVIST M: Effect ofethanol on the hydroxylation of tyrosine and tryptophan in rat brain in vivo. Pharm. Pharmacol (1973) 25:437–440.
   PubMed Web of Science ®Google Scholar
• TABAKOFF B, HOFFMAN PL: Alterations in receptors controlling dopamine synthesis after chronic ethanol ingestion. I Neurochem. (1978) 31:1223–1229.
   PubMedGoogle Scholar
• FADDA F, ARGIOLAS A, MELTS MR, SERRA G, GESSA GL: Differential effect of acute and chronic ethanol on dopamine metabolism in frontal cortex, caudate nucleus and substantia nigra. Life Science (1980) 27:979–986.
   PubMedGoogle Scholar
• CARLSSON A, MAGNUSSON T, SVESSON TH, WALDECK B: The effect of subhypnotic doses of ethanol on regional catecholamines turnover. Psychopharmacologia (Berlin) (1973) 30:27–36.
   PubMedGoogle Scholar
• LAI H, MAKOUS WL, HORITA A, LEUNG H: Effects of ethanol on turnover and function of striatal dopamine. Psychopharmacology (1979) 61:1–9.
   PubMedGoogle Scholar
• IMPERATO A, DI CHIARA G: stimulation of dopamine release in the nucleus accumbens of freely moving rats by ethanol. I Pharmacol Exp. Ther. (1986) 239:219–228.
   PubMed Web of Science ®Google Scholar
• ••Seminal paper demonstrating that alcohol,such as other drugs of abuse, stimulates the mesolimbic dopamine "reward" system.
   Google Scholar
• WOZNIAK KM, PERT A, MELE A, LINNOILA M: Focal application of alcohols elevates extracellular dopamine in rats brain: a microdialysis study. Blain Res. (1991) 540:31–40.
   Google Scholar
• YOSHIMOTO K, MCBRIDE WJ, LUMENG L, LI T-K: Alcohol stimulates the release of dopamine and serotonin in the nucleus accumbens. Alcohol (1991) 9:17–22.
   Web of Science ®Google Scholar
• BLANCHARD BA, STEINDORF S, WANG S, GLICK SD: Sex differences in ethanol-induced dopamine release in nucleus accumbens and in ethanol in rats. Alcohol Chi]. Exp. Res. (1993) 17:968–973.
   PubMedGoogle Scholar
• HEIDBREDER C, DE WITTE P: Ethanol differentially affects extracellular monoamines and GABA in the nucleus accumbens. Pharmacol Biochem. Behav. (1993) 46:477–481.
   PubMedGoogle Scholar
• BLOMQVIST O, ERICSON M, ENGEL JA, SODERPALM B: Accumbal dopamine overflow after ethanol: Localization of the antagonizing effect of mecamylamine. Eur. ?Pharmacol. (1997) 334:149–156.
   PubMed Web of Science ®Google Scholar
• WILLIAMS-HEMBY L, PORRINO LJ: Low to moderate doses of ethanol produce distinct patterns of cerebral metabolic changes in rats. Alcohol. Chi]. Exp. Res. (1994) 18:982–988.
   PubMedGoogle Scholar
• WEISS F, LORANG MT, BLOOM FE, KOOB GF: Oral alcohol self-administration stimulates dopamine release in the rat nucleus accumbens: genetic and motivational determinants. j Pharmacol Exp. Ther. (1993) 267:250–258.
   PubMed Web of Science ®Google Scholar
• •This paper reports the activating effect of voluntarily consumed alcohol on the rat mesolimbic dopamine system.
   Google Scholar
• GONZALES RA, WEISS F: Suppression of ethanol-reinforced behaviour by naltrexone is associated with attenuation of the ethanol-induced increase in dialysate dopamine levels in the nucleus accumbens. ?Neurosci. (1998) 24:10663–10671.
   Google Scholar
• SODERPALM B, ERICSON M, OLAUSSON P, BLOMQVIST O, ENGEL JA: Nicotinic mechanism involved in the dopamine activating and reinforcing properties of ethanol. Behav. Brain Res. (2000) 113:85–96.
   PubMed Web of Science ®Google Scholar
• LINSEMAN MA: Effects of dopaminergic agents on alcohol consumption by rats in a limited access paradigm. Psychopharmacology (1990) 100:195–200.
   PubMedGoogle Scholar
• DYR W, COX R, MCBRIDE WJ, LUMENG L, LI T-K, MURPHY JM: Operant responding for ethanol in high HAD and low LAD alcohol-drinking rats. Alcohol. Chi]. Exp. Res. (1993) 17:479.
   Google Scholar
• NG G, GEORGE SR: Dopamine receptor agonist reduces ethanol self-administration in the ethanol-preferring C57BL/6J inbred mouse. Eur. j Pharmacol (1994) 269:365–374.
   PubMed Web of Science ®Google Scholar
• PFEFFER AO, SAMSON HH: Haloperidol and apomorphine effects on ethanol reinforcement in free feeding rats. Pharmacol. Biochem. Behav. (1988) 29:343–350.
   PubMed Web of Science ®Google Scholar
• •Elegant, experimental demonstration on the "blockade" and "replacement" mechanisms of drugs capable of reducing alcohol consumption.
   Google Scholar
• WOLFFGRAMM J, GALLI G, THIMMF, HEYNE A: Animal models of addiction: models for therapeutic strategies? I Neural Trarism. (2000) 107:649–668.
   Google Scholar
• DIANA M, PISTIS M, CARBONI S, GESSA GL, ROSSETTI ZL: Profound decrement of mesolimbic dopaminergic neuronal activity during ethanol withdrawal syndrome in rats: electrophysiological and biochemical evidence. Proc. Nati Acad. Li. USA (1993) 90:7966–7969.
   PubMed Web of Science ®Google Scholar
• WEISS F, PARSON LH, SCHULTEIS Get al.: Ethanol self-administration restores withdrawal-associated deficiencies in accumbal dopamine and 5-hydroxytryptamine release in dependent rats. j Neurosci. (1996) 16:3474–3485.
   Google Scholar
• BORG V: Bromocriptine in the prevention of alcohol abuse. Acta Psychiat. Scarid. (1983) 68:110–110.
   Google Scholar
• POWELL BJ, CAMPBELL JL, LANDON JF et al: A double-blind, placebo-controlled study of nortriptyline and bromocriptine in male alcoholics subtyped by comorbid psychiatric disorders. Alcohol. Chi]. Exp. Res. (1995) 19:462–468.
   PubMed Web of Science ®Google Scholar
• JOHNSON BA, AIT-DAOUD N: Neuropharmacological treatments for alcoholism: scientific basis and clinical findings. Psychopharmacology (2000) 149:327–344.
   PubMed Web of Science ®Google Scholar
• •Recent review on pharmacotherapies for alcoholism.
   Google Scholar
• SCHMIDT LG, DUFEU P, KUHN S, ROMMELSPACHER H: Relapse prevention in alcoholics with an anticraving drug treatment: first results of the Berlin study. Pharmacopsychiatry (1994) 27\(Suppl. 1):21–23.
   Google Scholar
• WIESBECK GA, WEIJERS H-G, LESCH OM, GLASER T, TOENNES P-J, BOENING J. Flupenthixol decanoate and relapse prevention in alcoholics: results from a placebo-controlled study. A/colto/A/coltd. (2001) 36:329–334.
   Google Scholar
• FROEHLICH JC, LI T-K: Opioid involvement in alcohol drinking. In: Models of Neuropeptide Action. Strand FL, Beckwith W, Chronwall B, Sandman SA (Eds.), Ann. NY Acad. Sci. (1994) 739:156–167.
   Google Scholar
• HUBBELL CL, ABELSON ML, WILD KD, NEUMAN R, REID LD: Further studies of opioids and intake of sweetened beverage. Alcohol (1988) 5:141–146.
   PubMed Web of Science ®Google Scholar
• WILD KD, MARGLIN SH, REID LD: Small doses of morphine enhance voluntary intake of a solution of only ethanol and water. Bull. Psychori. Soc. (1988) 26:129–131.
   Google Scholar
• NICHOLS ML, HUBBELL CL, KALSHER MJ, REID LD: Morphine increases intake of beer among rats. Alcohol (1991) 8:237–240.
   PubMedGoogle Scholar
• HUBBELL CL, MANKES RF, REID LD: A small dose of morphine leads rats to drink more alcohol and achieve higher blood alcohol concentrations. Alcohol. Chh. Exp. Res. (1993) 17:1040–1043.
   PubMedGoogle Scholar
• SINCLAIR JD: Morphine-induced suppression of voluntary alcohol drinking in rats. Nature (1973) 246:425–427.
   PubMed Web of Science ®Google Scholar
• MYERS RD, BORG S, MOSSBERG R: Antagonism by naltrexone of voluntary alcohol selection in the chronically drinking macaque monkey. Alcohol (1986) 3:383–388.
   PubMedGoogle Scholar
• SINCLAIR JD: Drugs to decrease alcohol drinking. Ann. Med. (1990) 22:357–362.
   PubMed Web of Science ®Google Scholar
• •One of the first demonstration of the reducing effect of naltrexone on alcohol intake.
   Google Scholar
• KORNET M, GOOSEN C, VAN REE JM: Effect of naltrexone on alcohol consumption during chronic alcohol drinking and after a period of imposed abstinence in free-choice drinking rhesus monkeys. Psychopharmacology (1991) 104:367–376.
   PubMed Web of Science ®Google Scholar
• •First demonstration of the reducing effect of naltrexone on alcohol intake in non-human primates.
   Google Scholar
• WILLIAMS KL, WINGER G, PAKARINEN ED, WOODS JH: Naltrexone reduces ethanol- and sucrose-reinforced responding in rhesus monkeys. Psychopharmacology (1998) 139:53–61.
   PubMedGoogle Scholar
• BIENKOSWKY P, KOSTOWSKY W, KOROS E: Ethanol-reinforced behaviour in the rat: effects of naltrexone. Eur. Pharmacol. (1999) 374:321–327.
   PubMedGoogle Scholar
• HOLTER SM, SPANAGEL R: Effects of opiate antagonist treatment of the alcohol deprivation effect in long-term ethanol-experienced rats. Psychopharmacology (1999) 145:360–369.
   PubMed Web of Science ®Google Scholar
• JUNE HL, MCCANE SR, ZINK RW, PORTOGHESE PS, LI T-K, FROEHLICH JC: The 82-opioid receptor antagonist naltriben reduces motivated for ethanol. Psychopharmacology (1999) 147:81–89.
   PubMed Web of Science ®Google Scholar
• PARKES JH, SINCLAIR JD: Reduction of alcohol drinking and upregulation of opioid receptors by oral naltrexone in AA rats. Alcohol (2000) 21:215–221.
   PubMed Web of Science ®Google Scholar
• SINCLAIR JD: Evidence about the use of naltrexone and for different ways of using it in the treatment of alcoholism. Alcohol Alcohol. (2001) 36:2–10.
   PubMed Web of Science ®Google Scholar
• ••Elucidation on the mechanism of the anti-alcohol action of naltrexone, and specification of its greater efficacy when administered to non-abstinent alcoholics.
   Google Scholar
• ROBERTS AJ, MCDONALD JS, HEYSER CJ et al: p,-Opioid receptor knockout mice do not self-administer alcohol. j Pharmacol Exp. Ther. (2000) 293:1002–1008.
   PubMed Web of Science ®Google Scholar
• SCHULZ R, WUSTER M, DUKA T, HERZ A: Acute and chronic ethanol treatment changes endorphin levels in brain and pituitary. Psychopharmacology (1980) 68:221–227.
   PubMedGoogle Scholar
• GEORGE SR, ROLDAN L, LUI A, NARANJO CA: Endogenous opioids are involved in the genetically determined high preference for ethanol consumption. Alcoholism: Clin. Exp. Res. (1991) 15:668–672.
   PubMed Web of Science ®Google Scholar
• DE WAELE J-P, PAPACHRISTOU DN, GIANOULAKIS C: The alcohol-preferring C57BL/6J mouse present an enhanced sensitivity of the hypothalamic, b-endorphin system to ethanol than the alcohol-avoiding DBA/2 mice. j. Pharmacol Exp. Ther. (1992) 261:788–794.
   PubMedGoogle Scholar
• BENJAMIN D, GRANT ER, POHORECKY LA: Naltrexone reverses ethanol-induced dopamine release in the nucleus accumbens in awake, freely moving rats. Brain Res. (1993) 621:137–140.
   PubMed Web of Science ®Google Scholar
• ACQUAS E, MELONI M, DI CHIARA G: Blockade of 8-opioid receptors in the nucleus accumbens prevents ethanol-induced stimulation of dopamine release. Eur. Pharmacol (1993) 230:239–241.
   PubMed Web of Science ®Google Scholar
• VOLPICELLI JR, ALTERMAN Al, HAYASHIDA M, O'BREIN CP: Naltrexone in the treatment of alcohol dependence. Arch. Gen. Psychiatry (1992) 49:876–880.
   PubMed Web of Science ®Google Scholar
• •One of the two initial papers describing the efficacy of naltrexone in controlling alcohol consumption and relapses in alcoholics.
   Google Scholar
• O'MALLEY SS, JAFFE AJ, CHANG G, RS, MEYER RE, ROUNSAVILLE B: Naltrexone and coping skills therapy for alcohol dependence. Arch. Gen. Psychiatry (1992) 49:881-887. One of the two initial papers describing the efficacy of naltrexone in controlling alcohol consumption and relapses in alcoholics.
   Google Scholar
• MASON BJ, SALVATO FR, WILLIAMS LD, RITVO EC, CUTLER RB: A double-blind, placebo-controlled study of oral nalmefene for alcohol dependence. Arch. Gen. Psychiatry (1999) 56:719–724.
   PubMed Web of Science ®Google Scholar
• LEMARQUAND D, PIHL RO, BENKELFAT C: Serotonin and alcohol intake, abuse, and dependence: clinical evidence. Biol. Psychiatry (1994) 36:326–337.
   PubMed Web of Science ®Google Scholar
• LEMARQUAND D, PIHL RO, BENKELFAT C: Serotonin and alcohol intake, abuse, and dependence: findings of animals studies. Biol. Psychiatry (1994) 36:395–421.
   PubMed Web of Science ®Google Scholar
• •Comprehensive review of predinical data on the involvement of the brain serotonin system in the alcohol action.
   Google Scholar
• MURPHY JM, MCBRIDE WJ, LUMENG L, LI T-K: Regional brain levels of monoamines in alcohol-preferring and - nonpreferring lines of rats. Pharmacol. Biochem. Behav. (1982) 16:145–149.
   PubMed Web of Science ®Google Scholar
• GONGWER MA, MURPHY JM, MCBRIDE WJ, LUMENG L, LI T-K: Regional brain content of serotonin, dopamine and their metabolites in the selectively bred high- and low-alcohol drinking lines of rats. Alcohol (1989) 6:317–320.
   PubMed Web of Science ®Google Scholar
• DEVOTO E COLOMBO G, STEFANINI E, GESSA GL: Serotonin is reduced in the frontal cortex of Sardinian alcohol-preferring rats. Alcohol Alcohol. (1998) 33:226–229.
   PubMedGoogle Scholar
• CHU N-S, KEENAN L: Responses of midbrain dorsal raphe neurons to ethanol studied in brainstem slices. Alcohol (1987) 4:373–374.
   PubMedGoogle Scholar
• HIRSH JD: Selective inhibition of l3F11 lysergic acid diethylamide binding to mouse brain membranes by ethanol. ..J. Pharm. Pharmacol (1981) 33:475–477.
   PubMedGoogle Scholar
• BUCKHOLTZ N, ZHOU D, TABAKOFF B: Ethanol does not affect serotonin receptor binding in rodent brain. Alcohol (1989) 6:277–280.
   PubMedGoogle Scholar
• HELLEVUO K, HOFFMAN PL, TABAKOFF B: Ethanol fails to modify 3H1GR65630 binding to 5-HT3 receptors in NCB-20 cells and in rat cerebral membranes. Alcoholism: Clin. Exp. Res. (1991) 15:775–778.
   Google Scholar
• KILPATRICK GJ, JONES BJ, TYERS MB: Identification and distribution of 5-HT3receptors in rat brain using radioligand binding. Nature (1987) 330:746–748.
   PubMed Web of Science ®Google Scholar
• LOVINGER DM: Ethanol potentiation of 5-HT3 receptor-mediated ion current in NCB-20 neuroblastoma cells. Neurosci. Lett. (1991) 122:57–60.
   PubMedGoogle Scholar
• LOVINGER DM, WHITE G: Ethanol potentiation of 5-hydroxytryptamine3 receptor-mediated ion current in neuroblastoma cells and isolated adult mammalian neurons. Mol. Pharmacol. (1991) 40:263–270.
   PubMed Web of Science ®Google Scholar
• •First demonstration of the "agonistic" action of alcohol at the 5-HT3 subtype of the serotonin receptor.
   Google Scholar
• LOVINGER DM, ZHOU Q: Alcohols potentiate ion current mediated by recombinant 5-HT3RA receptors expressed in a mammalian cell line. Neuropharmacology (1994) 33:1567–1572.
   PubMed Web of Science ®Google Scholar
• GRANT KA, BARRETT JE: Blockade of the discriminative stimulus effects of ethanol with 5-HT3receptor antagonists. Psychopharmacology (1991) 104:451–456.
   PubMedGoogle Scholar
• •Evidence of the ability of 5-HT3 receptor antagonists to block the behavioral effects of alcohol.
   Google Scholar
• CARBONI E, ACQUAS E, FRAU R, DI CHIARA G: Differential inhibitory effects of a 5-HT3 antagonist on drug-induced stimulation of dopamine release. Eur. Pharmacol. (1989) 164:515–519.
   PubMed Web of Science ®Google Scholar
• YOSHIMOTO K, MCBRIDE WJ, LUMENG L, LI T-K: Ethanol enhances the release of dopamine and serotonin in the nucleus accumbens of HAD and LAD lines of rats. Alcohol. Clin. Exp. Res. (1992) 16:781–785.
   PubMed Web of Science ®Google Scholar
• FADDA F, GARAU B, MARCHEI E COLOMBO G, GESSA GL: MDL 72222, a selective 5-HT3 receptor antagonist, suppresses voluntary ethanol consumption in alcohol-preferring rats. Alcohol Alcohol. (1991) 26:107–110.
   PubMedGoogle Scholar
• KOSTOWSKI W, DYR W, KRZASCIK P: The ability of 5-HT3receptor antagonist ICS 205-930 to inhibit alcohol preference and withdrawal seizures in rats. Alcohol (1993) 10:369–373.
   PubMedGoogle Scholar
• MCKINZIE DL, MCBRIDE WJ, MURPHY JM, LUMENG L, LI T-K: of MDL 72222, a serotonin3 antagonist, on operant responding for ethanol by alcohol-preferring P rats. Alcohol. Clin. Exp. Res. (2000) 24:1500–1504.
   PubMedGoogle Scholar
• RODD-HENRICKS ZA, MCKINZIE DL et al.: Effects of 5-HT3 receptor antagonists on daily alcohol intake under acquisition, maintenance, and relapse conditions in alcohol-preferring (P) rats. Alcohol (2000) 21:73–85.
   PubMedGoogle Scholar
• •Demonstration of the ability of 5-HT3 receptor antagonists to block the acquisition of alcohol drinking behaviour in genetically selected alcohol-preferring rats.
   Google Scholar
• CORNELIUS JR, SALLOUM IM, EHLER JG et al.: Fluoxetine in depressed alcoholics. A double-blind, placebo controlled trial. Arch. Gen. Psychiatry(1997) 54:700–705.
   PubMed Web of Science ®Google Scholar
• JOHNSON BA: Serotonergic agents and alcoholism treatment: rebirth of the subtype concept - an hypothesis. Alcohol. Clin. Exp. Res. (2000) 24:1597–1601.
   PubMed Web of Science ®Google Scholar
• •Interesting hypothesis on the sensitivity of different subtypes of alcoholics to serotonergic agents.
   Google Scholar
• PETTINATI HM, VOLPICELLI JR, KRANZLER HR, LUCK G, RUKSTALIS MR, CNAAN A: Sertraline treatment for alcohol dependence: Interactive effects of medication and alcoholic subtype. Alcohol. Clin. Exp. Res. (2000) 24:1041–1049.
   PubMed Web of Science ®Google Scholar
• BABOR T, DOLINSKY Z, MEYER R, HESSELBROCK M, HOFMANN M, TENNEN H: Types of alcoholics: concurrent and predictive validity of some common classification schemes. Br. (1992) 87:1415–1431.
   Google Scholar
• ••Seminal paper proposing a classification ofalcoholic patient.
   Google Scholar
• JOHNSON BA, ROACHE JD, JAVORS MA, DICLEMENTE CC, CLONINGER CR, PRIHODA TJ, BORDNICK PS, AIT-DAOUD N, HENSLER J: Ondansetron for reduction of drinking among biologically predisposed alcoholic patients: A randomized controlled trial. ..J. Am. Med. Assoc. (2000) 284: 963–971.
   PubMed Web of Science ®Google Scholar
• HARRIS RA, HOOD WF: Inhibition of synaptosomal calcium uptake by ethanol. ..J. Pharmacol Exp. Ther. (1980) 213:562–568.
   PubMed Web of Science ®Google Scholar
• LESLIE SW, BARR E, CHANDLER J, FARRAR RP: Inhibition of fast- and slow-phase depolarization-dependent synaptosomal calcium uptake by ethanol. ..J. Pharmacol Exp. Ther. (1983) 225:571–575.
   PubMed Web of Science ®Google Scholar
• DOLIN S, LITTLE H, HUDSPITH M, C, LITTLETON J: Increased dihydropyridine-sensitive calcium channels in rat brain may underlie ethanol physical dependence. Neurophannacology (1987) 26:275–279.
   PubMed Web of Science ®Google Scholar
• WHITTINGTON MA, DOLIN SJ, PATCH TL, SIAREY RJ, BUTTERWORTH AR, LITTLE HJ: Chronic dihydropyridine treatment can reverse the behavioural consequences of and prevent adaptations to chronic ethanol treatment. Br j Pharmacol (1991) 103:1669–1676.
   PubMedGoogle Scholar
• LITTLE HJ, DOLIN SJ, HASLEY MJ: Calcium channel antagonists decrease the ethanol withdrawal syndrome. Life (1986) 39:2059–2065.
   Google Scholar
• BONE GHA, MAJCHROWICZ E, MARTIN PR, LINNOILA M, NUTT DJ: A comparison of calcium antagonists and diazepam in reducing ethanol withdrawal tremors. Psychophannacology (1989) 99:386–388.
   PubMedGoogle Scholar
• PUCILOWSKI O, KRZASCIK P, TRZASKOWSKA E, KOSTOWSKI W: Different effect of diazepam and nifedipine on some central actions of ethanol in the rat. Alcohol (1989) 6:165–168.
   PubMedGoogle Scholar
• COLOMBO G, AGABIO R, LOBINA C et al.: Effects of the calcium channel antagonist darodipine on ethanol withdrawal in rats. A/coho/A/cohoL (1995) 30:125–131.
   Google Scholar
• FADDA E GARAU B, COLOMBO G, GESSA GL: Israclipine and other calcium channel antagonists attenuate ethanol consumption in ethanol-preferring rats. Alcohol. Clin. Esp. Res. (1992) 16:449–452.
   PubMedGoogle Scholar
• DYR W, KRZASCIK E KOSTOWSKI W: Comparative study of nifedipine and isradipine in animal models of ethanol dependence. Poll Pharmacol. (1993) 45:369–379.
   PubMedGoogle Scholar
• PUCILOWSKI O, REZVANI AR, OVERSTREET DH, JANOWSKI DS: Calcium channel inhibitors attenuate consumption of ethanol, sucrose and saccharin solutions in rats. Behav. Pharmacol. (1994) 5:494–501.
   PubMedGoogle Scholar
• DE BEUN R, SCHNEIDER R, KLEIN A, LOHMANN A, DE VRY J: Effects of nimodipine and other calcium channel antagonists in alcohol-preferring AA rats. Alcohol (1996) 13:263–271.
   PubMed Web of Science ®Google Scholar
• GALLATE JE, SAHAROV T, MALLET PE, MCGREGOR IS: Increased motivation for beer in rats following administration of a CB1 receptor agonist. Eur. Pharmacol (1999) 370:233–240.
   PubMed Web of Science ®Google Scholar
• COLOMBO G, SERRA S, BRUNETTI G et al: Stimulation of voluntary ethanol intake by cannabinoid receptor agonists in ethanol-preferring sP rats. Psychopharmacology (2001) in press.
   Google Scholar
• ARNONE M, MARUANI J, CHAPERON THIEBOT M-E, PONCELET M, SOUBRIE P, LE FUR G: Selective inhibition of sucrose and ethanol intake by SR 141716, an antagonist of central cannabinoid (CBI) receptors. Psychopharmacology (1997) 132:104–106.
   PubMed Web of Science ®Google Scholar
• COLOMBO G, AGABIO R, FA M et al: Reduction of voluntary ethanol intake in ethanol-preferring sP rats by the cannabinoid antagonist SR 141716. Alcohol Alcohol. (1998) 33:126–130.
   PubMed Web of Science ®Google Scholar
• GALLATE JE, MCGREGOR IS: The motivation for beer in rats: effects of ritanserin, naloxone and SR 141716. Psychopharmacology (1999) 142:302–308.
   PubMed Web of Science ®Google Scholar
• •Interesting paper demonstrating that pharmacological blockade of the cannabinoid CBI receptor reduced the motivation to consume alcohol in rats.
   Google Scholar
• FREEDLAND CS, SHARPE AL, SAMSON HH, PORRINO LJ: Effects of 5R141716A on ethanol and sucrose self-administration. Alcohol. Chu. Exp. Res. (2001) 25:277–282.
   PubMedGoogle Scholar
• ARENDT T, ALLEN Y, SINDEN J, SCHUGENS MM, MARCHBANKS RM, LANTOS PL, GRAY JA: Cholinergic-rich brain transplants reverse alcohol-induced memory deficits. Nature (1988) 332:448–450.
   PubMed Web of Science ®Google Scholar
• •Important demonstration of the involvement of the acetylcholine system in alcohol-induced memory deficits.
   Google Scholar
• BERACOCHEA D, MICHEAU J, JAFFARD R: Memory deficits following chronic alcohol consumption in mice: relationship with hippocampal and cortical cholinergic activities. Pharmacol Biochem. Behav. (1992) 42:749–753.
   PubMedGoogle Scholar
• ILIEV A, TRAYKOV V, PRODANOV D et al: Effect of the acetylcholinesterase inhibitor galanthamine on learning and memory in prolonged alcohol intake rat model of acetylcholine deficit. Methods Find. Exp. Chu. Pharmacol (1999) 21:297–301.
   PubMedGoogle Scholar
• BROWN ZW, AMIT Z: The effects of selective catecholamine depletions by 6-hydroxydopamine on ethanol preference in rats. Neurosci. Letters (1977) 5:333–336.
   PubMedGoogle Scholar
• DAVIS WM, SMITH SG, WERNER TE: Noradrenergic role in the self-administration of ethanol. Pharmacol Biochem. Behav. (1978) 9:369–374.
   PubMedGoogle Scholar
• WEINSHENKERD, RUST NC, MILLER NS, PALMITER RD: Ethanol-associated behaviours of mice lacking norepinephrine. Neurosci. (2000) 20:3157–3164.
   Google Scholar
• ROSSETTI ZL, MELIS E CARBONI S, DIANA M, GESSA GL: Alcohol withdrawal in rats is associated with a marked fall in extraneuronal dopamine. Alcohol. CM]. Exp. Res. (1992) 16:529–532.
   PubMedGoogle Scholar
• BANERJEE SP, SHARMA VK, JM KHANNA: Alterations in 13-adrenergic receptor binding during ethanol withdrawal. Nature (1978) 276:407–409.
   PubMed Web of Science ®Google Scholar
• PARALE MP, KULKARNI SK: Studies with a2-adrenoceptor agonists and alcohol abstinence syndrome in rats. Psychopharmacology (1986) 88:237–239.
   PubMedGoogle Scholar
• RIIHOIOJA P, JAATINEN P, OKSANEN H, HAAPALINNA A, HEINONEN E, HERVONEN A: Dexmedetomidine, diazepam, and propranolol in the treatment of ethanol withdrawal symptoms in the rat. Alcohol. CM]. Exp. Res. (1997) 21:804–808.
   PubMedGoogle Scholar
• OLMEDO R, HOFFMAN RS: Withdrawal syndromes. Em. Med. Chu. North Am. (2000) 18:273–289.
   PubMedGoogle Scholar
• GUTHRIE SK: The treatment of alcohol withdrawal. Pharmacothetapy (1989) 9:131–143.
   PubMed Web of Science ®Google Scholar
• ROBINSON BJ, ROBINSON GM, MALING TJB, JOHNSON RH: Is clonidine useful in the treatment of alcohol withdrawal? Alcohol. Chu. Exp. Res. (1989) 13:95–98.
   PubMedGoogle Scholar
• CARAI M, AGABIO R, BOMBARDELLI E et al.: Potential use of medicinal plants in the treatment of alcoholism. Fitoterapia (2000) 71:S38–S42.
   Google Scholar
• KEUNG W-M, VALLEE BL: Daidzin and daidzein suppress free-choice ethanol intake by Syrian Golden hamsters. Proc. Nati Acad. Sci. USA (1993) 90:10008–10012.
   PubMedGoogle Scholar
• OVERSTREET DH, LEE Y-W, REZVANI AH, PEI Y-H, CRISWELL HE, JANOWSKY DS: Suppression of alcohol intake after administration of the Chinese herbal medicine, NPI-028, and its derivatives. Alcohol. Chu. Exp. Res. (1996) 20:221–227.
   PubMedGoogle Scholar
• XIE C-I, LIN RC, ANTONY V et al: Daidzin, an antioxidant isoflavonoid, decreases blood alcohol levels and shortens sleep time induced by ethanol intoxication.. Chu. Exp. Res. (1994) 18:1443–1447.
   PubMedGoogle Scholar
• COLOMBO G, AGABIO R, BOMBARDELLI E et al: Reduction of voluntary ethanol intake in ethanol-preferring sP rats by a soy extract. Alcohol. Chu. Exp. Res. (1999) 34:425.
   Google Scholar
• SANDERS B, COLLINS AC, PETERSEN DR, FISH BS: Effects of three monoamine oxidase inhibitors on ethanol preference in mice. Pharmacol Biochem. Behav. (1977) 6:319–324.
   PubMedGoogle Scholar
• COHEN C, CURET O, PERRAULT G, SANGER DJ: Reduction of oral ethanol self-administration in rats by monoamine oxidase inhibitors. Pharmacol Biochem. Behav. (1999) 64:535–539.
   PubMedGoogle Scholar